Saied A. Asbagh

FDA investigator

Appears on 12 documents from 2016 to 2024, most often at sites in California. Most often cites responsibilities of quality control unit (21 CFR 211.22).

12
Documents on file
3.4
Observations per 483
2016
First seen
2024
Most recent

What they cite most

From 41 observations

Activity by year

2016: 1, 2018: 1, 2019: 1, 2020: 2, 2021: 3, 2023: 3, 2024: 1

Where

California 4 · India 3 · Japan 2 · Israel 1 · Spain 1 · Utah 1

Often inspects with

Binh T. Nguyen· Darren S. Brown

Is Saied A. Asbagh coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

12 documents, newest first
FirmOpen
483 Paragon SwissJan 12, 2024 · Santa Clara, California
483 Rovi Pharma Industrial Services SAJun 2, 2023 · Alcala de Henares, Spain
483 Japan Food Research LaboratoriesMar 29, 2023 · Ibaraki, Osaka, Japan
483 Annora Pharma Private LimitedJan 20, 2023 · Sangareddy, India
483 Carlsbad Technology, Inc.Nov 5, 2021 · Carlsbad, California
483 Vitae Enim Vitae Scientific, Inc.Sep 22, 2021 · San Diego, California
483 Fresenius Medical Care North AmericaMay 21, 2021 · Ogden, Utah

About this profile

What does Saied A. Asbagh inspect?

Saied A. Asbagh appears on 12 documents on file covering 10 sites, most often in California.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.42 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Saied A. Asbagh is dated Jan 12, 2024.